• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定制模具近距离放射治疗在上颌骨切除术后上颌窦恶性肿瘤治疗中的应用:剂量学分析

Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: a dosimetric analysis.

作者信息

Ciérvide Raquel, Ramos Luis, Aristu Jose Javier, Montesdeoca Nestor, Martínez-Monge Rafael

机构信息

Radiation Oncology Division, Department of Oncology, Clínica Universitaria de Navarra, University of Navarre, Pamplona, Navarre, Spain.

出版信息

Brachytherapy. 2011 Mar-Apr;10(2):159-62. doi: 10.1016/j.brachy.2010.06.007. Epub 2010 Nov 19.

DOI:10.1016/j.brachy.2010.06.007
PMID:21093385
Abstract

PURPOSE

To explore the feasibility of a intraoral mold high-dose rate (HDR) brachytherapy in the treatment of tumors arising in the maxillary antrum after maxillectomy and to describe the dosimetric profile of HDR brachytherapy in such an unusual location.

METHODS AND MATERIALS

A customized mold with four 6-French catheters was designed and produced in transparent acrylic resin. The catheters formed a soft loop that allowed the passage of the HDR source. CT-based dose evaluation in several volumes of interest, including the gross tumor volume (GTV) and several organs at risk (OARs), such as the skin of the cheek, eyeball, lens, optic nerve, optic chiasm, and spinal cord was performed.

RESULTS

Treatments were delivered uneventfully. A favorable OAR/GTV ratio was observed. The GTV D(90) was covered by the 3.8 Gy isodose (95% of the prescription isodose of 4 Gy) and the doses received by the OARs varied between 4% and 43% of the prescription isodose for the V1 cc of spinal cord and eyeball, respectively. The only structure that could not be adequately spared was the skin overlying the tumoral lesion that received between 94% and 107% of the prescription isodose (1.0 and 0.5 cm(2) of skin, respectively).

CONCLUSIONS

Intraoral mold-based HDR brachytherapy can be used to treat tumors involving the maxillary antrum provided that access is possible through a previous maxillectomy. A dose reduction of 4-43% in several OARs, such as the spinal cord, pituitary gland, optic chiasm, optic nerve, eyeball, and lens, is obtained.

摘要

目的

探讨口腔模具高剂量率(HDR)近距离放射治疗在上颌骨切除术后上颌窦肿瘤治疗中的可行性,并描述在这种特殊部位进行HDR近距离放射治疗的剂量分布情况。

方法与材料

设计并制作了一种定制模具,带有四个6法国导管,由透明丙烯酸树脂制成。导管形成一个柔软的环,允许HDR源通过。在几个感兴趣的体积中进行基于CT的剂量评估,包括大体肿瘤体积(GTV)和几个危及器官(OARs),如脸颊皮肤、眼球、晶状体、视神经、视交叉和脊髓。

结果

治疗过程顺利。观察到良好的OAR/GTV比值。GTV D(90)被3.8 Gy等剂量线覆盖(4 Gy处方等剂量线的95%),脊髓和眼球的V1 cc的OARs接受的剂量分别为处方等剂量线的4%至43%。唯一不能充分避开的结构是肿瘤病变上方的皮肤,其接受的剂量为处方等剂量线的94%至107%(分别为1.0和0.5 cm(2)的皮肤)。

结论

基于口腔模具的HDR近距离放射治疗可用于治疗累及上颌窦的肿瘤,前提是通过先前的上颌骨切除术能够进行操作。在几个OARs中,如脊髓、垂体、视交叉、视神经、眼球和晶状体,剂量降低了4%至43%。

相似文献

1
Use of customized-mold brachytherapy in the management of malignancies arising in the maxillary antrum after maxillectomy: a dosimetric analysis.定制模具近距离放射治疗在上颌骨切除术后上颌窦恶性肿瘤治疗中的应用:剂量学分析
Brachytherapy. 2011 Mar-Apr;10(2):159-62. doi: 10.1016/j.brachy.2010.06.007. Epub 2010 Nov 19.
2
High-dose-rate brachytherapy for patients with maxillary gingival carcinoma using a novel customized intraoral mold technique.采用新型定制口腔内模具技术对上颌牙龈癌患者进行高剂量率近距离放射治疗。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Feb;109(2):e102-8. doi: 10.1016/j.tripleo.2009.10.019.
3
Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy.高剂量率定制模具近距离放射治疗上颌牙龈癌
Brachytherapy. 2008 Jul-Sep;7(3):267-9. doi: 10.1016/j.brachy.2008.04.001.
4
[Radiotherapy of maxillary antrum carcinoma].[上颌窦癌的放射治疗]
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):119-25.
5
Trans-osseous passage of head and neck brachytherapy tubes.头颈部近距离放射治疗管的经骨通道
Br J Plast Surg. 2000 Sep;53(6):520-1. doi: 10.1054/bjps.2000.3367.
6
A customized orofacial brachytherapy carrier: a clinical report.一种定制的口腔面部近距离放射治疗载体:一份临床报告。
J Prosthet Dent. 2005 Jan;93(1):24-7. doi: 10.1016/j.prosdent.2004.10.006.
7
Locally advanced verrucous carcinoma of the oral cavity: treatment using customized mold HDR brachytherapy instead of hemi-maxillectomy.口腔局部晚期疣状癌:采用定制模具 HDR 近距离放疗代替半侧上颌骨切除术的治疗。
Strahlenther Onkol. 2013 Oct;189(10):894-8. doi: 10.1007/s00066-013-0412-4. Epub 2013 Aug 22.
8
[An evaluation of the multidisciplinary treatment of carcinoma of the maxillary antrum in head and neck surgery].[头颈部外科中上颌窦癌多学科治疗的评估]
Gan No Rinsho. 1986 Oct;32(13):1737-41.
9
Rostral maxillectomy and radiation therapy to manage squamous cell carcinoma in a ferret.采用上颌前部切除术和放射疗法治疗雪貂的鳞状细胞癌。
Vet Clin North Am Exot Anim Pract. 2006 Sep;9(3):701-6. doi: 10.1016/j.cvex.2006.05.008.
10
Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.复发性或晚期头颈癌患者手术切除与高剂量率近距离放射治疗的联合应用。
J Craniomaxillofac Surg. 2008 Jul;36(5):285-92. doi: 10.1016/j.jcms.2007.08.009. Epub 2008 Mar 18.

引用本文的文献

1
High-dose-rate brachytherapy in severe trismus: Making it happen!严重牙关紧闭症的高剂量率近距离放射治疗:实现它!
J Contemp Brachytherapy. 2018 Aug;10(4):380-384. doi: 10.5114/jcb.2018.77958. Epub 2018 Aug 31.
2
Successful salvage treatment of refractory recurrence of maxillary sinus carcinoma using image-guided high-dose-rate interstitial brachytherapy.使用图像引导的高剂量率组织间近距离放射治疗成功挽救治疗上颌窦癌难治性复发
J Contemp Brachytherapy. 2018 Apr;10(2):162-168. doi: 10.5114/jcb.2018.75601. Epub 2018 Apr 30.
3
A simplified technique to fabricate tissue bolus device to manage dose distribution in maxillectomy patient with orbital exenteration.
一种制造组织填充物装置的简化技术,用于管理眼眶内容物剜除术的上颌骨切除患者的剂量分布。
J Oral Biol Craniofac Res. 2013 May-Aug;3(2):102-4. doi: 10.1016/j.jobcr.2013.03.005. Epub 2013 Apr 9.
4
Locally advanced verrucous carcinoma of the oral cavity: treatment using customized mold HDR brachytherapy instead of hemi-maxillectomy.口腔局部晚期疣状癌:采用定制模具 HDR 近距离放疗代替半侧上颌骨切除术的治疗。
Strahlenther Onkol. 2013 Oct;189(10):894-8. doi: 10.1007/s00066-013-0412-4. Epub 2013 Aug 22.